MicroRNAs and head and neck cancer: Reviewing the first decade of research

European Journal of Cancer

Volumn 50, Issue 15, 2014, Pages 2619-2635

  Sethi, Neeraj ^a   Wright, Alexander ^a   Wood, Henry ^a   Rabbitts, Pamela ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Biomarker; Gene expression; Head and neck cancer; MicroRNAs

Indexed keywords

MICRORNA; TUMOR MARKER;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK NEOPLASMS; HUMAN; MEDICAL RESEARCH; PROCEDURES; PROGNOSIS; TRENDS; TUMOR SUPPRESSOR GENE;

BIOMEDICAL RESEARCH; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; MICRORNAS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84907447004     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.07.012     Document Type: Review

References (172)

1. E.S. Lander Initial sequencing and analysis of the human genome Nature 409 2001 860 921
2. J.C. Venter The sequence of the human genome Science 291 2001 1304 1351
3. P. Carninci The transcriptional landscape of the mammalian genome Science 309 2005 1559 1563
4. M.I. Almeida, R.M. Reis, and G.A. Calin MicroRNA history: discovery, recent applications, and next frontiers Mutat Res 717 2011 1 8
5. W. Filipowicz, S.N. Bhattacharyya, and N. Sonenberg Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9 2008 102 114
6. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
7. V. Ambros The evolution of our thinking about microRNAs Nat Med 14 2008 1036 1040
8. A.E. Pasquinelli Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA Nature 408 2000 86 89
9. H. Siomi, and M.C. Siomi Posttranscriptional regulation of microRNA biogenesis in animals Mol Cell 38 2010 323 332
10. M.K. Bhayani, G.A. Calin, and S.Y. Lai Functional relevance of miRNA sequences in human disease Mutat Res 731 2012 14 19
11. R. Yi DGCR8-dependent microRNA biogenesis is essential for skin development Proc Natl Acad Sci U S A 106 2009 498 502
12. R. Yi, M.N. Poy, M. Stoffel, and E. Fuchs A skin microRNA promotes differentiation by repressing 'stemness' Nature 452 2008 225 229
13. K.R. Cordes MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity Nature 460 2009 705 710
14. M.D. Jansson, and A.H. Lund MicroRNA and cancer Mol Oncol 6 2012 590 610
15. M. Fabbri MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B Proc Natl Acad Sci U S A 104 2007 15805 15810
16. C.A. Gebeshuber, K. Zatloukal, and J. Martinez MiR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis EMBO Rep 10 2009 400 405
17. G.L. Ryland MicroRNA genes and their target 3′-untranslated regions are infrequently somatically mutated in ovarian cancers PLoS One 7 2012 e35805
18. M. Wu Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs Carcinogenesis 29 2008 1710 1716
19. S. Peng Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population Dig Dis Sci 55 2010 2288 2293
20. T. Tian A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese Cancer Epidemiol Biomarkers Prev 18 2009 1183 1187
21. X. Song MicroRNA variants increase the risk of HPV-associated squamous cell carcinoma of the oropharynx in never smokers PLoS One 8 2013 e56622
22. Y.H. Chu Impacts of microRNA gene polymorphisms on the susceptibility of environmental factors leading to carcinogenesis in oral cancer PLoS One 7 2012 e39777
23. Z. Orsos Association of pre-miR-146a rs2910164 polymorphism with the risk of head and neck cancer Anticancer Res 33 2013 341 346
24. B.C. Christensen Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer Clin Cancer Res 16 2010 3713 3720
25. J. Clague Genetic variation in MicroRNA genes and risk of oral premalignant lesions Mol Carcinog 49 2010 183 189
26. H.F. Tu The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma PLoS One 7 2012 e51606
27. K. Kozaki, I. Imoto, S. Mogi, K. Omura, and J. Inazawa Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer Cancer Res 68 2008 2094 2105
28. E.D. Wiklund MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma PLoS One 6 2011 e27840
29. S.M. Langevin MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck Cancer 117 2011 1454 1462
30. H. Hu The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2) J Biol Chem 288 2013 10973 10985
31. J. Dang MicroRNA-137 promoter methylation in oral lichen planus and oral squamous cell carcinoma J Oral Pathol Med 42 2013 315 321
32. P.K. Ha, and J.A. Califano Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma Lancet Oncol 7 2006 77 82
33. J. Minor Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas Oral Oncol 48 2012 73 78
34. E.J. Wee Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer Oncogene 31 2012 4182 4195
35. X. Zhang Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas Cancer Cell 22 2012 506 523
36. N. Nohata Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma Br J Cancer 108 2013 1648 1658
37. A. Jakymiw Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells Genes Chromosomes Cancer 49 2010 549 559
38. S. Chiosea Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma Am J Pathol 169 2006 1812 1820
39. Y. Karube Reduced expression of Dicer associated with poor prognosis in lung cancer patients Cancer Sci 96 2005 111 115
40. W.M. Merritt Dicer, Drosha, and outcomes in patients with ovarian cancer N Engl J Med 359 2008 2641 2650
41. H. Ma Genetic variations in key microRNA processing genes and risk of head and neck cancer: a case-control study in Chinese population PLoS One 7 2012 e47544
42. X. Zhang MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer Carcinogenesis 31 2010 2118 2123
43. A. Frenzel, J. Loven, and M.A. Henriksson Targeting MYC-regulated miRNAs to combat cancer Genes Cancer 1 2010 660 667
44. A.F. Waitzberg Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas Cancer Detect Prev 28 2004 178 186
45. N. Agrawal Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 Science 333 2011 1154 1157
46. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
47. M. Gasco, and T. Crook The p53 network in head and neck cancer Oral Oncol 39 2003 222 231
48. F. Ganci Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients Ann Oncol 24 2013 3082 3088
49. C.J. Liu MiR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma Cancer Res 70 2010 1635 1644
50. B.C. Christensen A let-7 microRNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancers Carcinogenesis 30 2009 1003 1007
51. X. Guan A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer FASEB J 27 2013 1404 1412
52. X. Liu MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma FEBS Lett 584 2010 4115 4120
53. M. Castoldi A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA) RNA 12 2006 913 920
54. P.P. Medina, M. Nolde, and F.J. Slack OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma Nature 467 2010 86 90
55. F. Meng, H. Wehbe-Janek, R. Henson, H. Smith, and T. Patel Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes Oncogene 27 2008 378 386
56. T. Papagiannakopoulos, A. Shapiro, and K.S. Kosik MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells Cancer Res 68 2008 8164 8172
57. Y. Guo Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma Cancer Res 68 2008 26 33
58. L.B. Frankel Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells J Biol Chem 283 2008 1026 1033
59. M. Dillhoff, J. Liu, W. Frankel, C. Croce, and M. Bloomston MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival J Gastrointest Surg 12 2008 2171 2176
60. Z.W. Yu MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines Oral Oncol 46 2010 317 322
61. P.P. Reis Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma Mol Cancer 9 2010 238
62. T.S. Wong Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue Clin Cancer Res 14 2008 2588 2592
63. L. Scapoli MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression Int J Immunopathol Pharmacol 23 2010 1229 1234
64. N. Kikkawa MiR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC) Br J Cancer 103 2010 877 884
65. A.B. Hui Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas Clin Cancer Res 16 2010 1129 1139
66. G. Childs Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma Am J Pathol 174 2009 736 745
67. S.S. Chang MicroRNA alterations in head and neck squamous cell carcinoma Int J Cancer 123 2008 2791 2797
68. M. Avissar, B.C. Christensen, K.T. Kelsey, and C.J. Marsit MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma Clin Cancer Res 15 2009 2850 2855
69. N.K. Cervigne Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma Hum Mol Genet 18 2009 4818 4829
70. M. Rentoft MiRNA analysis of formalin-fixed squamous cell carcinomas of the tongue is affected by age of the samples Int J Oncol 38 2011 61 69
71. K. Gombos MiRNA expression profiles of oral squamous cell carcinomas Anticancer Res 33 2013 1511 1517
72. J. Li MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor Clin Cancer Res 15 2009 3998 4008
73. M. Avissar, M.D. McClean, K.T. Kelsey, and C.J. Marsit MicroRNA expression in head and neck cancer associates with alcohol consumption and survival Carcinogenesis 30 2009 2059 2063
74. Y. Chen Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis J Pathol 200 2003 640 646
75. J. Ren, D. Zhu, M. Liu, Y. Sun, and L. Tian Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma Eur J Cancer 46 2010 3409 3416
76. H.M. Jung Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer J Biol Chem 287 2012 29261 29272
77. C. Darido Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis Cancer Cell 20 2011 635 648
78. J.G. Zhang MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC) Clin Chim Acta 411 2010 846 852
79. W. Wang, P. Songlin, Y. Sun, B. Zhang, and W. Jinhui MiR-21 inhibitor sensitizes human OSCC cells to cisplatin Mol Biol Rep 39 2012 5481 5485
80. L.Y. Bourguignon, C. Earle, G. Wong, C.C. Spevak, and K. Krueger Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells Oncogene 31 2012 149 160
81. P. Cao Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma Head Neck 35 2013 720 728
82. M. Saito The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts Clin Cancer Res 17 2011 1875 1882
83. F. Wang, Z. Zheng, J. Guo, and X. Ding Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor Gynecol Oncol 119 2010 586 593
84. I. Faraoni, F.R. Antonetti, J. Cardone, and E. Bonmassar MiR-155 gene: a typical multifunctional microRNA Biochim Biophys Acta 1792 2009 497 505
85. M.I. Rather, M.N. Nagashri, S.S. Swamy, K.S. Gopinath, and A. Kumar Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics J Biol Chem 288 2013 608 618
86. X.D. Zhao, W. Zhang, H.J. Liang, and W.Y. Ji Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3 PLoS One 8 2013 e56395
87. L. Ramdas MiRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue Head Neck 31 2009 642 654
88. I. Ivanovska MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression Mol Cell Biol 28 2008 2167 2174
89. B.L. Li MiR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer Med Oncol 30 2013 484
90. K.W. Lai MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer Eur J Cancer 46 2010 1456 1463
91. C.B. Lajer Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study Br J Cancer 104 2011 830 840
92. E.M. Pinatel MiR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions PLoS One 9 2014 e84859
93. J. Li MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4 J Cancer Res Clin Oncol 138 2012 763 774
94. H.E. Gee Hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer Cancer 116 2010 2148 2158
95. H. Wu MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2 IUBMB Life 63 2011 101 108
96. L. Gao Downregulation of miR-145 expression in oral squamous cell carcinomas and its clinical significance Onkologie 36 2013 194 199
97. T.H. Chu MiR-211 promotes the progression of head and neck carcinomas by targeting TGFbetaRII Cancer Lett 337 2013 115 124
98. X. Li, H.L. Wang, X. Peng, H.F. Zhou, and X. Wang MiR-1297 mediates PTEN expression and contributes to cell progression in LSCC Biochem Biophys Res Commun 427 2012 254 260
99. C.J. Chang Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer Oncol Rep 26 2011 1003 1010
100. E. Bandres Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues Mol Cancer 5 2006 29
101. K. Motoyama Over- and under-expressed microRNAs in human colorectal cancer Int J Oncol 34 2009 1069 1075
102. Q.W. Wong MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1 Gastroenterology 135 2008 257 269
103. L.X. Yan MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis RNA 14 2008 2348 2360
104. A. Schaefer Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma Int J Cancer 126 2010 1166 1176
105. C.J. Creighton Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers Cancer Res 70 2010 1906 1915
106. E.M. Laurila, S. Sandstrom, L.M. Rantanen, R. Autio, and A. Kallioniemi Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells Genes Chromosomes Cancer 51 2012 557 568
107. S. Valastyan, A. Chang, N. Benaich, F. Reinhardt, and R.A. Weinberg Activation of miR-31 function in already-established metastases elicits metastatic regression Genes Dev 25 2011 646 659
108. Y. Tsukamoto MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta Cancer Res 70 2010 2339 2349
109. D. Sun MiR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation Cancer Res 71 2011 1313 1324
110. Z. Chen Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma Oral Oncol 48 2012 686 691
111. B. Yan Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells Mol Med Rep 6 2012 675 681
112. T. Harris Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas Am J Pathol 180 2012 917 928
113. A.B. Hui Significance of dysregulated metadherin and microRNA-375 in head and neck cancer Clin Cancer Res 17 2011 7539 7550
114. H.M. Jung Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions Mol Biol Cell 24 1638-48 2013 S1 S7
115. H. Nakanishi Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway Oncogene 33 2014 702 712
116. B.J. Henson, S. Bhattacharjee, D.M. O'Dee, E. Feingold, and S.M. Gollin Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy Genes Chromosomes Cancer 48 2009 569 582
117. M. Shiiba MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma Br J Cancer 108 2013 1817 1821
118. G.K. Scott Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b J Biol Chem 282 2007 1479 1486
119. S.A. Maclellan Differential expression of miRNAs in the serum of patients with high-risk oral lesions Cancer Med 1 2012 268 274
120. W.H. Yang, H.Y. Lan, S.K. Tai, and M.H. Yang Repression of bone morphogenetic protein 4 by let-7i attenuates mesenchymal migration of head and neck cancer cells Biochem Biophys Res Commun 433 2013 24 30
121. S.M. Johnson RAS is regulated by the let-7 microRNA family Cell 120 2005 635 647
122. C.C. Yu MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation Oral Oncol 47 2011 202 210
123. T. Kinoshita Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma Br J Cancer 109 2013 2636 2645
124. Y. Jin Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma Int Rev Cell Mol Biol 303 2013 357 385
125. H. Endo Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer Carcinogenesis 34 2013 560 569
126. Q. Sun Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin Int J Biochem Cell Biol 45 2013 513 520
127. A. Peschiaroli MiR-143 regulates hexokinase 2 expression in cancer cells Oncogene 32 2013 797 802
128. J.S. Kim MicroRNA-205 suppresses the oral carcinoma oncogenic activity via down-regulation of Axin-2 in KB human oral cancer cell Mol Cell Biochem 387 2014 71 79
129. T. Sasahira Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer Br J Cancer 107 2012 700 706
130. B. Kumar, A. Yadav, J. Lang, T.N. Teknos, and P. Kumar Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis PLoS One 7 2012 e37601
131. T. Kinoshita Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma Int J Oncol 40 2012 1770 1778
132. Y. Guo, W. Fu, H. Chen, C. Shang, and M. Zhong MiR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein Oncol Rep 27 2012 1097 1103
133. X. Liu MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines Biochem J 440 2011 23 31
134. T. Zhang Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression Anticancer Res 31 2011 3859 3863
135. R. Banerjee The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma Oncogene 30 2011 4339 4349
136. N. Nohata MiR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma Oncotarget 2 2011 29 42
137. W.L. Lo MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells J Pathol 223 2011 482 495
138. K.H. Shin MiR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras Biochem Biophys Res Commun 404 2011 896 902
139. S. Hunt, A.V. Jones, E.E. Hinsley, S.A. Whawell, and D.W. Lambert MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1 FEBS Lett 585 2011 187 192
140. T. Venkatesh Primary microcephaly gene MCPH1 shows signatures of tumor suppressors and is regulated by miR-27a in oral squamous cell carcinoma PLoS One 8 2013 e54643
141. W.C. Huang MiRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis Cancer Res 74 2014 751 764
142. X. Liu MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines Cancer Lett 286 2009 217 222
143. B. Kefas MicroRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma Cancer Res 68 2008 3566 3572
144. R.J. Webster Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7 J Biol Chem 284 2009 5731 5741
145. F.C. Kalinowski Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7 PLoS One 7 2012 e47067
146. L. Jiang MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells Biochem J 432 2010 199 205
147. L.G. Wang MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met Int J Oncol 42 2013 957 962
148. Y. Xu, and G.J. Fisher Role of met axis in head and neck cancer Cancers (Basel) 5 2013 1601 1618
149. -is negatively associated with recurrent/newly formed oral leukoplakia PLoS One 7 2012 e38648
150. Y. Yang Progress risk assessment of oral premalignant lesions with saliva miRNA analysis BMC Cancer 13 2013 129
151. N.J. Park Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection Clin Cancer Res 15 2009 5473 5477
152. C.J. Liu, S.C. Lin, C.C. Yang, H.W. Cheng, and K.W. Chang Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma Head Neck 34 2012 219 224
153. L. Ayaz, A. Gorur, H.Y. Yaroglu, C. Ozcan, and L. Tamer Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma J Cancer Res Clin Oncol 139 2013 1499 1506
154. C.Z. Xu Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell Int J Clin Exp Pathol 6 2013 2745 2756
155. C.Z. Xu Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line Int J Clin Exp Pathol 6 2013 1351 1361
156. E.A. Ratovitski Phospho-DeltaNp63alpha-dependent microRNAs modulate chemoresistance of squamous cell carcinoma cells to cisplatin: at the crossroads of cell life and death FEBS Lett 587 2013 2536 2541
157. C.M. Hsu Circulating miRNA is a novel marker for head and neck squamous cell carcinoma Tumour Biol 33 2012 1933 1942
158. C.J. Liu Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer Oral Dis 16 2010 360 364
159. A.I. Wald, E.E. Hoskins, S.I. Wells, R.L. Ferris, and S.A. Khan Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus Head Neck 33 2011 504 512
160. C.B. Lajer The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer Br J Cancer 106 2012 1526 1534
161. A.B. Hui Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma Clin Cancer Res 19 2013 2154 2162
162. G. Gao A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma Cancer 119 2013 72 80
163. S.Y. Wu MicroRNA-17-5p post-transcriptionally regulates p21 expression in irradiated betel quid chewing-related oral squamous cell carcinoma cells Strahlenther Onkol 189 2013 675 683
164. Y.S. Tsai Areca nut induces miR-23a and inhibits repair of DNA double-strand breaks by targeting FANCG Toxicol Sci 123 2011 480 490
165. N. Nohata Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC) J Hum Genet 56 2011 595 601
166. A. Pal Cigarette smoke condensate promotes pro-tumourigenic stromal-epithelial interactions by suppressing miR-145 J Oral Pathol Med 42 2013 309 314
167. P. Brennan Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review Am J Epidemiol 159 2004 1 16
168. G. Menvielle, D. Luce, P. Goldberg, I. Bugel, and A. Leclerc Smoking, alcohol drinking and cancer risk for various sites of the larynx and hypopharynx. A case-control study in France Eur J Cancer Prev 13 2004 165 172
169. G. Menvielle, D. Luce, P. Goldberg, and A. Leclerc Smoking, alcohol drinking, occupational exposures and social inequalities in hypopharyngeal and laryngeal cancer Int J Epidemiol 33 2004 799 806
170. M. Lindenbergh-van der Plas Identification of lethal microRNAs specific for head and neck cancer Clin Cancer Res 19 2013 5647 5657
171. L. Piao Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma Mol Ther 20 2012 1261 1269
172. M.A. Rahman Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth J Control Release 159 2012 384 392